Company Profiles

driven by the PitchBook Platform

Avidity Biosciences

Description

Developer of an antibody cancer therapy utilizing nanoparticle technology. The company is engaged in the research, development and manufacture of drug candidates for the treatment of cancer and other serious diseases. Its drug candidates include antibody-siRNA complexes that are drawn on the features of antibody-drug conjugates and nucleic acid-based medicines

2012

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$16M

Latest Deal Amount

$25M

Total Amount Raised

Description

Developer of an antibody cancer therapy utilizing nanoparticle technology. The company is engaged in the research, development and manufacture of drug candidates for the treatment of cancer and other serious diseases. Its drug candidates include antibody-siRNA complexes that are drawn on the features of antibody-drug conjugates and nucleic acid-based medicines

Website:

www.aviditybiosciences.com

Formerly Known As

Avidity NanoMedicines

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

10975 North Torrey Pines Road Suite 150, La Jolla San Diego, CA 92037United States +1 (858) 401-7900
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Avidity Biosciences's full profile, request a free trial.

Avidity Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Avidity Biosciences Investors (11)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alethea Capital ManagementOtherMinority000 0000000 0000
Alexandria Real Estate EquitiesReal EstateMinority000 0000000 0000
Brace Pharma CapitalOtherMinority000 0000000 0000
EcoR1 CapitalHedge FundMinority000 0000000 0000
F-Prime Capital PartnersVenture CapitalMinority000 0000000 0000
Alethea Capital Management Other
Alexandria Real Estate Equities Real Estate
Brace Pharma Capital Other
EcoR1 Capital Hedge Fund
F-Prime Capital Partners Venture Capital

Avidity Biosciences Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Leigh ElkolliDirector, Finance
Anneke RaneyDirector, Program Management and Operations
P. Kent HawrylukCo-Founder & Chief Business Officer
Arthur Levin Ph.DExecutive Vice President, Research & Development
Frank McCormick Ph.DCo-Founder
Leigh Elkolli Director, Finance
Anneke Raney Director, Program Management and Operations
P. Kent Hawryluk Co-Founder & Chief Business Officer
Arthur Levin Ph.D Executive Vice President, Research & Development
Frank McCormick Ph.D Co-Founder

Avidity Biosciences Board Members (5)

NameRepresentingRoleSinceContact
Info
Benjamin AuspitzBoard Observer000 0000
Eran Nadav Ph.DTPG BiotechManaging Director & Partner000 0000
Michael Martin Ph.DTakeda VenturesSenior Investment Director & Global Head000 0000
Todd BradyBrace Pharma CapitalDirector, Finance000 0000
Tony HsuAlethea Capital ManagementFounder & Chief Investment Officer000 0000
Benjamin Auspitz Board Observer
Eran Nadav Ph.D Managing Director & Partner TPG Biotech
Michael Martin Ph.D Senior Investment Director & Global Head Takeda Ventures
Todd Brady Director, Finance Brace Pharma Capital
Tony Hsu Founder & Chief Investment Officer Alethea Capital Management
Request full access to PitchBook